The right clinical trial tech stack isn’t the most complete one; it’s the one built with sites, funded fairly, and designed to remove friction, not add it.
- The Risks And Unresolved Rules Of Real-Time Clinical Trials
- What Real-Time Clinical Trials Demand From Your Tech Stack
- The FDA's RTCT Push: What It Is; Why It Matters
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
ON-DEMAND WEBINARS
Watch as experts from ActiGraph, Bellerophon Therapeutics, and IQVIA come together to explore the obstacles and potential breakthroughs in rare disease research.
Want to know more about the growth and expansion of IRT in the decentralized trial space? Witness how IRT is being used to support direct-to-patient delivery in this hybrid trial case study.
The benefits of integrating EHR data with an EDC range from reducing duplicate documentation and errors to enriching the clinical dataset with real-world data. Why aren’t more people doing it?
This webinar discusses the types of master protocols and how configurable, modern RTSM systems enable fast and seamless mid-study changes to help you efficiently run your master protocol study.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1426935964 DCTs]( "With The Emergence Of DCTs, Do We Really Need A CTMS?")
With The Emergence Of DCTs, Do We Really Need A CTMS?As decentralized trial designs continue to grow in popularity, do sponsors and CROs really need a clinical trial management system? Explore whether CTMS is necessary with the emergence of DCTs.
-
![ai-pre-award-landscape-analysis-GettyImages-2092028381]( "What The Joint FDA And EMA's AI Principles Can Mean For Clinical Trial Technology")
What The Joint FDA And EMA's AI Principles Can Mean For Clinical Trial TechnologyNew FDA/EMA principles align global expectations for AI in drug trials, emphasizing transparency, human-centric design, and risk-based governance to ensure data integrity and patient safety.
-
![top-10-trends-GettyImages-2231462868]( "Top 10 HEOR Trends Report")
Top 10 HEOR Trends ReportEmerging trends in HEOR reveal how AI, real‑world evidence, value‑based care, digital health, and evolving affordability pressures are reshaping global healthcare.
-
![Future Digital Transformation GettyImages-1297914649]( "Study Start-Up Checklist For Digital Clinical Trials")
Study Start-Up Checklist For Digital Clinical TrialsRead how five Florence employees with clinical research backgrounds came together to craft a checklist designed to walk sites through the process of tech-enabled study start-up.
-
![GettyImages-1480239219 data platform]( "Clinical Trial Insights: Integrating Direct Data Capture With EDC")
Clinical Trial Insights: Integrating Direct Data Capture With EDCBy capturing data directly from the source, discover how researchers access insights faster and make more informed decisions.
-
![GettyImages-1302453801 trial design ps]( "Considerations For Implementing The Best eCOAs In Your Trial Design")
Considerations For Implementing The Best eCOAs In Your Trial DesignDive into considerations when deciding on the best COAs to implement as well as best practices when developing your eCOA strategy in this blog.
-
![gettyimages-915254256-170667a]( "How eCOA Improves Patient Experience")
How eCOA Improves Patient ExperienceExplore how to ensure that clinical trials are truly patient-centered, and why it is critical to do so.
-
![Big data-GettyImages-1023943076]( "Modern Post-Market Trials Driven By RWD – Is Your EDC Ready?")
Modern Post-Market Trials Driven By RWD – Is Your EDC Ready?Explore the transformative role of real-world data (RWD) and advanced Electronic Data Capture (EDC) systems in post-market research, marking a departure from traditional Phase IV trials.
-
![GettyImages-2155531148 electronic data, ePRO, eCOA]( "Maximizing Site Performance: The Hidden Benefits Of Unified eConsent And EDC")
Maximizing Site Performance: The Hidden Benefits Of Unified eConsent And EDCDisconnected systems for eConsent and EDC create inefficiencies that burden clinical trial teams, but modern integrated platform solutions are streamlining operations.
-
![Competitive Intel_Data Detective_Getty_1273843154]( "Enhancing Competitive Intelligence In Pharma With Comprehensive Data Analysis")
Enhancing Competitive Intelligence In Pharma With Comprehensive Data AnalysisDiscover a unified platform that turns complex pharma data into clear, strategic insights, empowering teams to outpace competitors with evidence-backed decisions from pipeline to launch.
RECENT NEWSLETTERS
- 06.11.26 -- AI Governance, Site Tech Risk, And Trial Efficiency Gains
- 06.06.26 -- Best Of May: AI Risk, CRO Strategy, And Trial Cost Control
- 06.04.26 -- Why Clinical Execution — Not Tech — Is Trials' Biggest Risk
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials
